traditional Chinese medicine formula No.1

Traditional Chinese medicine formula No.1 is an individualized herbal preparation developed by the Yunnan Provincial Hospital of Traditional Chinese Medicine (The No.1 Affiliated Hospital of Yunnan University of Traditional Chinese Medicine). It is currently being investigated in clinical trials for the treatment of rheumatoid arthritis, specifically as an adjunctive therapy to standard disease-modifying antirheumatic drugs (DMARDs) such as methotrexate and leflunomide. The primary therapeutic objective of incorporating this formula into the treatment regimen is to facilitate the tapering and eventual discontinuation of glucocorticoids (e.g., prednisone) while maintaining disease control and preventing flares. As a traditional Chinese medicine (TCM) intervention, the formula likely comprises a complex mixture of botanical extracts designed to modulate immune function and reduce systemic inflammation according to TCM diagnostic patterns.